Browsing: neutral on biocon

Money

Biocon: This pharma stock can give a high return of 25%, a big deal of 330 crores will be a booster, brokerage house’s opinion

By Business KhabarMarch 2, 2022

Biocon’s subsidiary Biocon Biologics recently inked a major $333 million deal to acquire the business of biosimilar player Viatris Inc.…